Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 84.4 HKD -1.4%
Market Cap: 144.6B HKD

Intrinsic Value

The intrinsic value of one Innovent Biologics Inc stock under the Base Case scenario is 51.26 HKD. Compared to the current market price of 84.4 HKD, Innovent Biologics Inc is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
51.26 HKD
Overvaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Innovent Biologics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Innovent Biologics Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Innovent Biologics Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Innovent Biologics Inc.

Explain Valuation
Compare Innovent Biologics Inc to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Innovent Biologics Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Innovent Biologics Inc

Current Assets 13.1B
Cash & Short-Term Investments 9.5B
Receivables 1.7B
Other Current Assets 1.8B
Non-Current Assets 10.5B
Long-Term Investments 2.6B
PP&E 5.7B
Intangibles 1.4B
Other Non-Current Assets 899.9m
Current Liabilities 5B
Accounts Payable 432.3m
Other Current Liabilities 4.6B
Non-Current Liabilities 4.2B
Long-Term Debt 2.3B
Other Non-Current Liabilities 1.9B
Efficiency

Free Cash Flow Analysis
Innovent Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Innovent Biologics Inc

Revenue
11.4B CNY
Cost of Revenue
-1.7B CNY
Gross Profit
9.8B CNY
Operating Expenses
-8.4B CNY
Operating Income
1.4B CNY
Other Expenses
-234.2m CNY
Net Income
1.1B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Innovent Biologics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
46/100
Profitability
Score

Innovent Biologics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Innovent Biologics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
81/100
Solvency
Score

Innovent Biologics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Innovent Biologics Inc

Wall Street analysts forecast Innovent Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 107.28 HKD with a low forecast of 40.4 HKD and a high forecast of 144.27 HKD.

Lowest
Price Target
40.4 HKD
52% Downside
Average
Price Target
107.28 HKD
27% Upside
Highest
Price Target
144.27 HKD
71% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Innovent Biologics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Innovent Biologics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

News

Other Videos
What is the Intrinsic Value of one Innovent Biologics Inc stock?

The intrinsic value of one Innovent Biologics Inc stock under the Base Case scenario is 51.26 HKD.

Is Innovent Biologics Inc stock undervalued or overvalued?

Compared to the current market price of 84.4 HKD, Innovent Biologics Inc is Overvalued by 39%.

Back to Top